Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Genome-wide Hypomethylation in Human Glioblastomas Associated with Specific Copy Number Alteration, Methylenetetrahydrofolate Reductase Allele Status, and Increased Proliferation
2006
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2005
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
2005 StandoutScience
Cabozantinib in Progressive Medullary Thyroid Cancer
2013
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Transforming activity of MECT1‐MAML2 fusion oncoprotein is mediated by constitutive CREB activation
2005
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Pan-cancer patterns of somatic copy number alteration
2013
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
2016
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
2013
Thyroid cancer
2016 Standout
Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer
2015
c-Myb and Bcl-x Overexpression Predicts Poor Prognosis in Colorectal Cancer
2001
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
DNA methylation patterns and epigenetic memory
2002 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Ovarian cancer
2014 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference
2007
The Outcomes and Costs of Acute Myeloid Leukemia Among the Elderly
2002
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
2006
Small, dense low‐density‐lipoproteins and the metabolic syndrome
2006
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
SomaticRASMutations Occur in a Large Proportion of SporadicRET-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified Exon
2012
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Myelodysplastic Syndromes
2004
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
The Cancer Genome Atlas Pan-Cancer analysis project
2013 Standout
The Epigenomics of Cancer
2007 Standout
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
EGF–ERBB signalling: towards the systems level
2006 Standout
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes
2004
Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma
2007
Methylation matters
2001
Discoidin domain receptor tyrosine kinases: new players in cancer progression
2012
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
DNA methylation in cancer: too much, but also too little
2002
Estrogen Receptor Analysis for Breast Cancer
2005
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
2005
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
2003
Remodelling the extracellular matrix in development and disease
2014 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
TNF-α targeted therapeutic approaches in patients with hematologic malignancies
2002
NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach
2003
High Expression of the CC Chemokine TARC in Reed-Sternberg Cells
1999
The 17q12-q21 amplicon: Her2 and topoisomerase-IIα and their importance to the biology of solid tumours
2006
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Cancer and the chemokine network
2004 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Advances in the follow-up of differentiated or medullary thyroid cancer
2012
Management of advanced medullary thyroid cancer
2015
Discovery and saturation analysis of cancer genes across 21 tumour types
2014 StandoutNature
Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes
2007
Alternative activation of macrophages
2003 Standout
Methylation inhibitor therapy in the treatment of myelodysplastic syndrome
2005
CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine
2007
Prognostic Scoring Systems in Patients with Follicular Thyroid Cancer: A Comparison of Different Staging Systems in Predicting the Patient Outcome
2004
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
2012
Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer
2012
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
RNA fingerprints provide direct evidence for the inhibitory role of TGFβ and PD-1 on CD4+ T cells in Hodgkin lymphoma
2007
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Stem Cell Factor and Hematopoiesis
1997
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Characterization of CD30/CD30L+Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis
2015
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's Oncology Group Phase I Consortium Report
2010
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Phase I/II Study of the Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) in Patients with Relapsed or Refractory Hematologic Malignancies
2006
S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
2003
DNA Copy Number Gains at Loci of Growth Factors and Their Receptors in Salivary Gland Adenoid Cystic Carcinoma
2007
Stem Cell Factor and Hematopoiesis
1997
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors
2000
Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
2008
RASMutations in Thyroid FNA Specimens Are Highly Predictive of Predominantly Low-Risk Follicular-Pattern Cancers
2013
Immunobiology of Dendritic Cells
2000 Standout
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
1998
Diversity of mutations in theRETproto-oncogene and its oncogenic mechanism in medullary thyroid cancer
2015
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
The role of cytokines in classical Hodgkin lymphoma
2002
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
2011 StandoutNobel
Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies
2002
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
2007
Works of António E. Pinto being referenced
Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer
2005
c-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER +) breast cancer patients with poor prognosis
2001
Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma
1997
High Prevalence of RAS Mutations in RET -Negative Sporadic Medullary Thyroid Carcinomas
2011
DNA Ploidy is an Independent Predictor of Survival in Breast Invasive Ductal Carcinoma: A Long-term Multivariate Analysis of 393 Patients
2012
Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas
2009
Hodgkin's disease: a tumor with disturbed immunological pathways
1997
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
1998
DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis
1996
Malignant salivary gland neoplasms: a cytogenetic study of 19 cases
1996
Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas
2007
Global DNA hypomethylation in breast carcinoma
1999
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
1999
Global DNA hypomethylation in breast carcinoma
1999
Follicular thyroid carcinoma: Chromosome analysis of 19 cases
1998
Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.
1997
Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas
1994
Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study
2004
Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes
1999
Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line
1996
Report of an international working group to standardize response criteria for myelodysplastic syndromes.
2000